Further evidence for CD5 expression involvement in IBD comes from recent report showing that inducible Cd5-deficient mice in the autoimmune-prone non-obese diabetic (NOD) background undergo exacerbated DSS-induced colitis by modifying T cell effector function (58). The gene discussed is CD5; the disease is inflammatory bowel disease.